- Home
- Publications
- Publication Search
- Publication Details
Title
Mitoxantrone, More than Just Another Topoisomerase II Poison
Authors
Keywords
-
Journal
MEDICINAL RESEARCH REVIEWS
Volume 36, Issue 2, Pages 248-299
Publisher
Wiley
Online
2015-08-19
DOI
10.1002/med.21364
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Berberine suppresses gero-conversion from cell cycle arrest to senescence
- (2016) Hong Zhao et al. Aging-US
- Dexrazoxane may prevent doxorubicin-induced DNA damage via depleting both Topoisomerase II isoforms
- (2014) Shiwei Deng et al. BMC CANCER
- Phase I clinical trial of pegylated liposomal mitoxantrone plm60-s: pharmacokinetics, toxicity and preliminary efficacy
- (2014) Jianliang Yang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Proteolytic Degradation of Topoisomerase II (Top2) Enables the Processing of Top2·DNA and Top2·RNA Covalent Complexes by Tyrosyl-DNA-Phosphodiesterase 2 (TDP2)
- (2014) Rui Gao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nanodiamond–Mitoxantrone Complexes Enhance Drug Retention in Chemoresistant Breast Cancer Cells
- (2014) Tan-Boon Toh et al. MOLECULAR PHARMACEUTICS
- Inhibition of c-Abl Kinase Activity Renders Cancer Cells Highly Sensitive to Mitoxantrone
- (2014) Kemal Alpay et al. PLoS One
- Mitoxantrone Targets the ATP-binding Site of FAK, Binds the FAK Kinase Domain and Decreases FAK, Pyk-2, c-Src, and IGF-1R In Vitro Kinase Activities
- (2013) Vita M. Golubovskaya et al. Anti-Cancer Agents in Medicinal Chemistry
- Inactivation of PTEN increases ABCG2 expression and the side population through the PI3K/Akt pathway in adult acute leukemia
- (2013) Fang-Fang Huang et al. CANCER LETTERS
- Topoisomerase 2β: A Promising Molecular Target for Primary Prevention of Anthracycline-Induced Cardiotoxicity
- (2013) P Vejpongsa et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pegylated liposomal mitoxantrone is more therapeutically active than mitoxantrone in L1210 ascitic tumor and exhibits dose-dependent activity saturation effect
- (2013) ChunLei Li et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- A New Target for an Old Drug: Identifying Mitoxantrone as a Nanomolar Inhibitor of PIM1 Kinase via Kinome-Wide Selectivity Modeling
- (2013) Xiaobo Wan et al. JOURNAL OF MEDICINAL CHEMISTRY
- On the structural basis and design guidelines for type II topoisomerase-targeting anticancer drugs
- (2013) Chyuan-Chuan Wu et al. NUCLEIC ACIDS RESEARCH
- Lysine-Specific Demethylase 1 in Breast Cancer Cells Contributes to the Production of Endogenous Formaldehyde in the Metastatic Bone Cancer Pain Model of Rats
- (2013) Jia Liu et al. PLoS One
- Application of a Novel Microtitre Plate-Based Assay for the Discovery of New Inhibitors of DNA Gyrase and DNA Topoisomerase VI
- (2013) James A. Taylor et al. PLoS One
- A Novel High Throughput Biochemical Assay to Evaluate the HuR Protein-RNA Complex Formation
- (2013) Vito G. D’Agostino et al. PLoS One
- Replication-Dependent and Transcription-Dependent Mechanisms of DNA Double-Strand Break Induction by the Topoisomerase 2-Targeting Drug Etoposide
- (2013) Margaret Tammaro et al. PLoS One
- A novel small-molecule screening strategy identifies mitoxantrone as a RhoGTPase inhibitor
- (2012) Aurélien Bidaud-Meynard et al. BIOCHEMICAL JOURNAL
- Identification of the molecular basis of doxorubicin-induced cardiotoxicity
- (2012) Sui Zhang et al. NATURE MEDICINE
- Identification of Potential Small Molecule Binding Pockets on Rho Family GTPases
- (2012) Juan Manuel Ortiz-Sanchez et al. PLoS One
- MRE11 facilitates the removal of human topoisomerase II complexes from genomic DNA
- (2012) K. C. Lee et al. Biology Open
- Recent Advances in Developing Small Molecules Targeting RNA
- (2011) Lirui Guan et al. ACS Chemical Biology
- M2, a novel anthracenedione, elicits a potent DNA damage response that can be subverted through checkpoint kinase inhibition to generate mitotic catastrophe
- (2011) Benny J. Evison et al. BIOCHEMICAL PHARMACOLOGY
- Phosphorylation of p53 on Ser15 during cell cycle and caused by Topo I and Topo II inhibitors in relation to ATM and Chk2 activation
- (2011) Hong Zhao et al. CELL CYCLE
- Mitoxantrone Inhibits HIF-1 Expression in a Topoisomerase II-Independent Pathway
- (2011) Y.-M. Toh et al. CLINICAL CANCER RESEARCH
- Discovery of selective bioactive small molecules by targeting an RNA dynamic ensemble
- (2011) Andrew C Stelzer et al. Nature Chemical Biology
- Harnessing synthetic lethal interactions in anticancer drug discovery
- (2011) Denise A. Chan et al. NATURE REVIEWS DRUG DISCOVERY
- The MRE11 complex: starting from the ends
- (2011) Travis H. Stracker et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Unraveling the mechanism of BRCA2 in homologous recombination
- (2011) William K Holloman NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Structural Basis of Type II Topoisomerase Inhibition by the Anticancer Drug Etoposide
- (2011) C.-C. Wu et al. SCIENCE
- Oxidative metabolism of the anti-cancer agent mitoxantrone by horseradish, lacto-and lignin peroxidase
- (2010) Thomas B. Brück et al. BIOCHIMIE
- Mitoxantrone in combination with an inhibitor of DNA-dependent protein kinase: a potential therapy for high risk B-cell chronic lymphocytic leukaemia
- (2010) Sarah L. Elliott et al. BRITISH JOURNAL OF HAEMATOLOGY
- Targeting DNA repair in breast cancer: A clinical and translational update
- (2010) Eitan Amir et al. CANCER TREATMENT REVIEWS
- New biomarkers probing depth of cell senescence assessed by laser scanning cytometry
- (2010) Hong Zhao et al. CYTOMETRY PART A
- Analysis of t(15;17) chromosomal breakpoint sequences in therapy-related versus de novo acute promyelocytic leukemia: Association of DNA breaks with specific DNA motifs at PML and RARA loci
- (2010) Syed Khizer Hasan et al. GENES CHROMOSOMES & CANCER
- Expression of Noncoding Vault RNA in Human Malignant Cells and Its Importance in Mitoxantrone Resistance
- (2010) S. C. B. Gopinath et al. MOLECULAR CANCER RESEARCH
- Cardiotoxicity of anticancer treatments: what the cardiologist needs to know
- (2010) Michael S. Ewer et al. Nature Reviews Cardiology
- Genotoxic stress causes the accumulation of the splicing regulator Sam68 in nuclear foci of transcriptionally active chromatin
- (2010) Roberta Busà et al. NUCLEIC ACIDS RESEARCH
- Tumor Tissue-Derived Formaldehyde and Acidic Microenvironment Synergistically Induce Bone Cancer Pain
- (2010) Zhiqian Tong et al. PLoS One
- Can Anthracycline Therapy for Pediatric Malignancies Be Less Cardiotoxic?
- (2010) Joy M. Fulbright et al. Current Oncology Reports
- The Centrality of RNA
- (2009) Phillip A. Sharp CELL
- PTEN/PI3K/Akt Pathway Regulates the Side Population Phenotype and ABCG2 Activity in Glioma Tumor Stem-like Cells
- (2009) Anne-Marie Bleau et al. Cell Stem Cell
- Structural Basis for Stabilization of the Tau Pre-mRNA Splicing Regulatory Element by Novantrone (Mitoxantrone)
- (2009) Suxin Zheng et al. CHEMISTRY & BIOLOGY
- Rad52
- (2009) Uffe H. Mortensen et al. CURRENT BIOLOGY
- Myeloperoxidase Genotypes and Enhanced Efficacy of Chemotherapy for Early-Stage Breast Cancer in SWOG-8897
- (2009) Christine B. Ambrosone et al. JOURNAL OF CLINICAL ONCOLOGY
- Mitoxantrone Analogues as Ligands for a Stem−Loop Structure of Tau Pre-mRNA
- (2009) Yang Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- DNA repair deficiency and neurological disease
- (2009) Peter J. McKinnon NATURE REVIEWS NEUROSCIENCE
- Identification and Characterization of Inhibitors of Human Apurinic/apyrimidinic Endonuclease APE1
- (2009) Anton Simeonov et al. PLoS One
- Kinetics of histone H2AX phosphorylation and Chk2 activation in A549 cells treated with topotecan and mitoxantrone in relation to the cell cycle phase
- (2008) Hong Zhao et al. CYTOMETRY PART A
- Cellular processing pathways contribute to the activation of etoposide-induced DNA damage responses
- (2008) Jia-Rong Fan et al. DNA REPAIR
- NK314, a Topoisomerase II Inhibitor That Specifically Targets the α Isoform
- (2008) Eriko Toyoda et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fas-mediated killing of primary prostate cancer cells is increased by mitoxantrone and docetaxel
- (2008) J. C. Symes et al. MOLECULAR CANCER THERAPEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started